Among patients with mCSPC, the same comparison yielded a numerically higher risk estimate of OS (HR: 2.16, 95% CI: 1.43–3.25); however, the difference did not reach statistical significance ( p = 0.247).
← all excerpts
The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis.
1
0.2470
0.2470